More from the DAD Study on Antiretrovirals and MI Risk
An increased risk for myocardial infarction was found with recent exposure to abacavir and ddI and with cumulative exposure to abacavir, indinavir, and lopinavir/ritonavir.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)